Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Peoples Bancorp of North Carolina
PEBK
$231M
| $340K | ﹤0.01% |
12,473
| – | – |
|
|
BIOA
3177
BioAge Labs
BIOA
$488M
| $338K | ﹤0.01% |
89,977
+5,110
| +6% | +$23.6K |
|
3178
Empire Petroleum
EP
$99.1M
| $337K | ﹤0.01% |
53,631
+14,328
| +36% | +$92K |
|
3179
Perma-Fix Environmental Services
PESI
$374M
| $336K | ﹤0.01% |
46,244
+6,009
| +15% | +$54K |
|
3180
Gencor Industries
GENC
$212M
| $335K | ﹤0.01% |
27,533
+20
| +0.1% | +$284 |
|
3181
Virco
VIRC
$95.5M
| $333K | ﹤0.01% |
35,178
| – | – |
|
3182
Arq
ARQ
$88M
| $332K | ﹤0.01% |
79,646
| – | – |
|
3183
Amer Sports
AS
$21.4B
| $331K | ﹤0.01% |
12,386
+2,275
| +23% | +$67.3K |
|
3184
iShares MSCI USA Min Vol Factor ETF
USMV
$24B
| $330K | ﹤0.01% |
3,520
-1
| -0% | -$92 |
|
3185
Nerdy
NRDY
$105M
| $327K | ﹤0.01% |
230,229
-309
| -0.1% | -$520 |
|
3186
Alto Neuroscience
ANRO
$1.09B
| $325K | ﹤0.01% |
150,421
-4,410
| -3% | -$15.8K |
|
|
TRUE
3187
DELISTED
TrueCar
TRUE
| $323K | ﹤0.01% |
204,613
-40,763
| -17% | -$113K |
|
3188
NI Holdings
NODK
$315M
| $323K | ﹤0.01% |
22,655
+1
| +0% | +$15 |
|
3189
INmune Bio
INMB
$50.5M
| $323K | ﹤0.01% |
41,320
+6,654
| +19% | +$52.8K |
|
3190
Kyverna Therapeutics
KYTX
$464M
| $319K | ﹤0.01% |
165,370
-4,410
| -3% | -$13K |
|
3191
Korro Bio
KRRO
$166M
| $318K | ﹤0.01% |
18,288
+790
| +5% | +$23.4K |
|
3192
LivePerson
LPSN
$26.1M
| $318K | ﹤0.01% |
26,551
+1,744
| +7% | +$31K |
|
3193
Contango Silver & Gold Inc
CTGO
$610M
| $317K | ﹤0.01% |
31,089
| – | – |
|
3194
Lifeway Foods
LWAY
$449M
| $316K | ﹤0.01% |
12,909
+1
| +0% | +$22 |
|
3195
Core Molding Technologies
CMT
$209M
| $316K | ﹤0.01% |
20,759
| – | – |
|
|
RGLS
3196
DELISTED
Regulus Therapeutics
RGLS
| $313K | ﹤0.01% |
178,879
| – | – |
|
3197
Southland Holdings
SLND
$36.9M
| $311K | ﹤0.01% |
103,917
+23,004
| +28% | +$74.7K |
|
|
SUNS
3198
Sunrise Realty Trust
SUNS
$104M
| $311K | ﹤0.01% |
28,067
+12,000
| +75% | +$144K |
|
3199
EVI Industries
EVI
$180M
| $311K | ﹤0.01% |
18,509
+3,529
| +24% | +$61.6K |
|
|
APLT
3200
DELISTED
Applied Therapeutics
APLT
| $309K | ﹤0.01% |
632,529
-68,307
| -10% | -$40.2K |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.